Cargando…

Erratum to: Editorial: mRNA Vaccines and Future Epidemic, Pandemic, and Endemic Zoonotic Virus Infections. Med Sci Monit. 2021;27:e932899, doi: 10.12659/MSM.932899

Detalles Bibliográficos
Autor principal:	Parums, Dinah V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2021
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109190/ https://www.ncbi.nlm.nih.gov/pubmed/33947822 http://dx.doi.org/10.12659/MSM.932986

Ejemplares similares

Erratum for Euro Surveill. 2021;27(30)
Publicado: (2022)

Erratum for Euro Surveill. 2021;27(42)
Publicado: (2022)

Editorial: mRNA Vaccines and Future Epidemic, Pandemic, and Endemic Zoonotic Virus Infections
por: Parums, Dinah V.
Publicado: (2021)

MONIT: Monitoring the CERN Data Centres and the WLCG Infrastructure
por: Aimar, Alberto, et al.
Publicado: (2019)

Editorial: Current Status of Non-Endemic Global Infections with the Monkeypox Virus
por: Parums, Dinah V.
Publicado: (2022)

Erratum to ‘History and future of hepatitis B virus control in South Korea’ [Clin Mol Hepatol 2021;27:620-622]
por: Kim, Do Young
Publicado: (2022)

Letter to the Editor regarding: Negative pressure wound therapy: Re: Wang X, Zhang Y, Han C: Topical negative pressure improves autograft take by altering nutrient diffusion: A hypothesis. Med Sci Monit, 2014; 20: 61–63
por: Dohmen, Pascal M.
Publicado: (2014)

Vets, Meds, and Zoonotic Threats
por: Pitlik, Silvio
Publicado: (2004)

Thieme MedOne ComSci
por: Antunez, Marilia Y.
Publicado: (2018)

Scott Co. Med. Sc’y.
por: Tomson, J. J.
Publicado: (1857)

Louisa Co. Med. Sc’y.
por: Taylor, T. G.
Publicado: (1857)

Letter to the Editor regarding: Epistatic effects in pathophysiology of asthma and the “missing heritability” of this disease: Re: Yoshikawa T, Kanazawa H, Fujimoto S, Hirata K.: Epistatic effects of multiple receptor genes on pathophysiology of asthma – its limits and potential for clinical application. Med Sci Monit, 2014, 20: 64–71
por: Brodziak, Andrzej, et al.
Publicado: (2014)

Publicly available datasets on thallium (Tl) in the environment—a comment on “Presence of thallium in the environment: sources of contaminations, distribution and monitoring methods” by Bozena Karbowska, Environ Monit Assess (2016) 188:640 (DOI 10.1007/s10661-016-5647-y)
por: de Caritat, Patrice, et al.
Publicado: (2017)

Letter to the Editor: Orthostatic Reactivity in Patients with Ischemic Stroke in the Chronic Period. OA Maced J Med Sci. http://dx.doi.org/10.3889/oamjms.2015.090
por: Vasileva, Danche
Publicado: (2015)

Editorial: First Full Regulatory Approval of a COVID-19 Vaccine, the BNT162b2 Pfizer-BioNTech Vaccine, and the Real-World Implications for Public Health Policy
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Global Regulatory Initiatives Deliver Accelerated Approval of the First Bispecific Therapeutic Monoclonal Antibody for Advanced Non-Small Cell Lung Cancer (NSCLC)
por: Parums, Dinah V.
Publicado: (2021)

Editorial: The First Monoclonal Antibody Vaccine to Prevent Malaria Heralds a New Era of Malaria Vaccines to the Plasmodium falciparum Circumsporozoite Protein (PfCSP)
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Autoantibodies to Components of the Immune System, Including Type 1 Interferons, and the Risk of Severe COVID-19
por: Parums, Dinah V.
Publicado: (2021)

Editorial: A Decline in Influenza During the COVID-19 Pandemic and the Emergence of Potential Epidemic and Pandemic Influenza Viruses
por: Parums, Dinah V.
Publicado: (2021)

Editorial: What Can be Learned from National and International Vaccine Adverse Event Reporting Systems During the COVID-19 Pandemic?
por: Parums, Dinah V.
Publicado: (2021)

Editorial: The 2021 European Society of Cardiology (ESC) Guidelines on the Real-World Prevention of Atherosclerotic Cardiovascular Disease (ASCVD)
por: Parums, Dinah V.
Publicado: (2021)

Editorial: The National COVID Cohort Collaborative Consortium Combines Population Data with Machine Learning to Evaluate and Predict Risk Factors for the Severity of COVID-19
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Review Articles, Systematic Reviews, Meta-Analysis, and the Updated Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 Guidelines
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Reporting Clinical Trials with Important Modifications Due to Extenuating Circumstances, Including the COVID-19 Pandemic: CONSERVE 2021
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Registries and Population Databases in Clinical Research and Practice
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Long COVID, or Post-COVID Syndrome, and the Global Impact on Health Care
por: Parums, Dinah V.
Publicado: (2021)

Retracted: Editorial: mRNA Vaccines and Immunotherapy in Oncology: A new Era for Personalized Medicine
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Post-Exposure Prophylactic Neutralizing Monoclonal Antibodies to SARS-CoV-2 for Individuals at High Risk for COVID-19
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Tocilizumab, a Humanized Therapeutic IL-6 Receptor (IL-6R) Monoclonal Antibody, and Future Combination Therapies for Severe COVID-19
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Multisystem Inflammatory Syndrome in Adults (MIS-A) and the Spectrum of COVID-19
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Global Initiatives Support the Use and Regulation of Digital Health Technology During the COVID-19 Pandemic
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Targets for Disease-Modifying Therapies in Alzheimer’s Disease, Including Amyloid β and Tau Protein
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Updates from the World Health Organization (WHO) on Global Treatment Recommendations for Drug-Susceptible and Multidrug-Resistant Tuberculosis
por: Parums, Dinah V.
Publicado: (2021)

Editorial: The 2022 World Health Organization (WHO) Priority Recommendations and Response to the Omicron Variant (B.1.1.529) of SARS-CoV-2
por: Parums, Dinah V.
Publicado: (2022)

Editorial: First Approval of the Protein-Based Adjuvanted Nuvaxovid (NVX-CoV2373) Novavax Vaccine for SARS-CoV-2 Could Increase Vaccine Uptake and Provide Immune Protection from Viral Variants
por: Parums, Dinah V.
Publicado: (2022)

Editorial: SARS-CoV-2 Vaccine Responses and Breakthrough COVID-19
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Cardiovascular Complications at One Year After SARS-CoV-2 Infection are Independent of Underlying Cardiovascular Risk Factors or Severity of COVID-19
por: Parums, Dinah V.
Publicado: (2022)

Editorial: Artificial Intelligence (AI) in Clinical Medicine and the 2020 CONSORT-AI Study Guidelines
por: Parums, Dinah V.
Publicado: (2021)

Editorial: SARS-CoV-2 mRNA Vaccines and the Possible Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)
por: Parums, Dinah V.
Publicado: (2021)

Editorial: mRNA Vaccines and Immunotherapy in Oncology: A New Era for Personalized Medicine
por: Parums, Dinah V.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nri4ml9gb6u6bfapgqabl7pu6f